Earnings Feed
Start Free
Home/Insiders/YOOR BRIAN B
YB
SEC Insider//CIK 0001643528

YOOR BRIAN B

CIK 00016435282 companiesSAN FRANCISCO, CA
SEC Profile

Transactions

45

Companies

2

Filings

8

CIK

0001643528

Recent Transactions

45 trades
  • Award
    iRhythm Holdings, Inc.$IRTC

    Common Stock

    2026-05-27+1,573→ 7,171 total
  • Award
    iRhythm Holdings, Inc.$IRTC

    Common Stock

    2025-05-28+1,358→ 5,598 total
  • Award
    iRhythm Holdings, Inc.$IRTC

    Common Stock

    2024-05-29+1,841→ 4,240 total
  • Award
    iRhythm Holdings, Inc.$IRTC

    Common Stock

    2023-06-01+2,399→ 2,399 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-02-28$79.19/sh−14,318→ 114,099 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-02-21+14,036→ 128,417 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-02-21+85,562→ 85,562 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-01-28−41,229→ 0 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-01-28−213,470→ 0 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-01-28−91,121→ 45,561 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-01-28−82,321→ 164,642 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$47.00/sh+41,229→ 155,610 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$44.40/sh+91,121→ 541,910 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$48.90/sh+81,709→ 237,319 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$38.40/sh+213,470→ 450,789 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$59.94/sh+82,321→ 624,231 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2020-01-28$89.73/sh−509,850→ 114,381 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2020-01-28−81,709→ 0 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2019-08-08−11,400→ 0 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-08-08$39.12/sh+32,363→ 158,144 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2019-08-08−32,363→ 0 total
  • Exercise/Conversion
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-08-08$34.94/sh+11,400→ 125,781 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-08-08$85.77/sh−43,763→ 114,381 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-03-01$78.00/sh−2,246→ 114,381 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-02-28$77.23/sh−13,127→ 116,627 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2019-02-22+169,198→ 169,198 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2019-02-22+32,279→ 129,754 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2018-06-01$61.53/sh−1,713→ 97,475 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2018-02-28$60.55/sh−7,379→ 99,188 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2018-02-16+44,909→ 106,567 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2018-02-16+246,963→ 246,963 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2017-06-01$45.66/sh−1,767→ 61,658 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2017-03-01$45.39/sh−1,728→ 63,425 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2017-02-28$45.46/sh−4,227→ 65,153 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2017-02-17+19,763→ 69,380 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2017-02-17+136,682→ 136,682 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-06-01$39.49/sh−565→ 49,617 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-06-01$39.63/sh−1,203→ 50,182 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-02-29$39.13/sh−700→ 51,385 total
  • Tax Payment
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-02-29$39.52/sh−1,840→ 52,250 total
  • Sale
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-02-29$39.12/sh−165→ 52,085 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2016-02-19+213,470→ 213,470 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2016-02-19+24,348→ 54,090 total
  • Award
    ABBOTT LABORATORIES$ABT

    Common shares without par value

    2015-06-01+11,596→ 29,742 total
  • Award
    ABBOTT LABORATORIES$ABT

    Option (right to buy)

    2015-06-01+81,709→ 81,709 total

Companies

2

Recent Filings

8

Address

C/O IRHYTHM HOLDINGS, INC. 699 8TH ST #600

SAN FRANCISCO, CA, 94103

View on SEC.gov